Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma: original article - Uluk, Deniz; Pein, Justus; Herda, Sophia; Schliephake, Frederik; Schneider, Carolin V.; Bitar, Jude; Dreher, Katharina; Eurich, Dennis; Zhang, Ingrid W.; Schaffrath, Lukas; Auer, Timo A.; Collettini, Federico; et al. (Alimentary pharmacology & therapeutics, 2025)
Gesehen am 03.12.2025